COVID-19 Post-Vaccination Observation

Yang I. Pachankis, PhD

Status: Active, not recruiting

Conditions: Immune System Disorder; COVID-19 Vaccine Adverse Reaction; Immune System Diseases

Study type: Observational

Identifiers

NCT06107348

SARS-Immune-00

Details and patient eligibility

About

The study started after the second COVID-19 vaccination of the participant with blood spots appearing on the skin with severe arthritis. The study continued to the third-dose full vaccination of the participant with the recombined COVID-19 vaccination and afterwards. The study completed until intervention.

Enrollment: 1 patient

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

All COVID-19 vaccinated are eligible for inclusion.

Trial design

1 participants in 1 patient group

Immune Disorder